Exploring DORAs for the Treatment of Insomnia
English
Recorded Courses
hosted by Pharmacy Times Continuing Education (PTCE)
hosted by Pharmacy Times Continuing Education (PTCE)
attend it anywhere online
category
Medicine, Pharmacy
Neurology
price
Free
Exploring DORAs for the Treatment of Insomnia is organized by Pharmacy Times Continuing Education (PTCE).,Release date: June 20, 2022,Expiration date: June 20, 2023,Description:,Insomnia is the most common sleep disorder in the United States, affecting nearly 70 million adults. The impact of insomnia is substantial; not only is it inconvenient for the patient, but it can also have a lasting impact on mental and physical well-being. Although it is a serious and growing condition, insomnia is both underrecognized and undertreated. Pharmacists are often the first health care professional those struggling with insomnia may interact with, and they have an important role in discussing healthy sleep habits, recognizing when referral to a provider is appropriate, and providing counseling on nonprescription and prescription therapies. This activity will provide pharmacists with information about the newest treatment class for insomnia, dual orexin receptor antagonists, including their action on the sleep-wake cycle, their efficacy and safety, and important counseling and monitoring considerations.,Educational Objectives:,At the completion of this activity, participants will be able to:,• Describe the epidemiology and pathophysiology of insomnia,• Review the role of dual orexin receptor antagonists to improve outcomes and quality of life for patients with insomnia,• Recognize the pharmacist’s role in monitoring and educating patients who exhibit signs and symptoms of insomnia